1. Home
  2. ADPT vs BFC Comparison

ADPT vs BFC Comparison

Compare ADPT & BFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADPT
  • BFC
  • Stock Information
  • Founded
  • ADPT 2009
  • BFC 1894
  • Country
  • ADPT United States
  • BFC United States
  • Employees
  • ADPT N/A
  • BFC N/A
  • Industry
  • ADPT Biotechnology: Biological Products (No Diagnostic Substances)
  • BFC Major Banks
  • Sector
  • ADPT Health Care
  • BFC Finance
  • Exchange
  • ADPT Nasdaq
  • BFC Nasdaq
  • Market Cap
  • ADPT 1.1B
  • BFC 1.1B
  • IPO Year
  • ADPT 2019
  • BFC N/A
  • Fundamental
  • Price
  • ADPT $9.03
  • BFC $112.30
  • Analyst Decision
  • ADPT Buy
  • BFC Buy
  • Analyst Count
  • ADPT 6
  • BFC 2
  • Target Price
  • ADPT $9.83
  • BFC $111.00
  • AVG Volume (30 Days)
  • ADPT 3.0M
  • BFC 25.4K
  • Earning Date
  • ADPT 05-01-2025
  • BFC 04-15-2025
  • Dividend Yield
  • ADPT N/A
  • BFC 4.66%
  • EPS Growth
  • ADPT N/A
  • BFC N/A
  • EPS
  • ADPT N/A
  • BFC 6.82
  • Revenue
  • ADPT $189,527,000.00
  • BFC $163,459,000.00
  • Revenue This Year
  • ADPT $21.20
  • BFC $12.55
  • Revenue Next Year
  • ADPT $21.99
  • BFC $5.79
  • P/E Ratio
  • ADPT N/A
  • BFC $16.51
  • Revenue Growth
  • ADPT 8.61
  • BFC N/A
  • 52 Week Low
  • ADPT $2.99
  • BFC $77.00
  • 52 Week High
  • ADPT $10.28
  • BFC $117.24
  • Technical
  • Relative Strength Index (RSI)
  • ADPT 57.82
  • BFC 57.43
  • Support Level
  • ADPT $8.38
  • BFC $112.80
  • Resistance Level
  • ADPT $9.51
  • BFC $119.04
  • Average True Range (ATR)
  • ADPT 0.66
  • BFC 2.62
  • MACD
  • ADPT 0.16
  • BFC 0.35
  • Stochastic Oscillator
  • ADPT 63.02
  • BFC 41.14

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).

About BFC Bank First Corporation

Bank First Corp is a United States-based company engaged in providing financial services provides a full range of consumer and commercial financial institution services to individuals and businesses including retail and commercial banking in Wisconsin. These services include credit cards; secured and unsecured consumer, commercial, and real estate loans; demand, time, and savings deposits; and ATM processing. The Corporation also offers a full line of insurance services and checking accounts, savings accounts, money market accounts, cash management accounts, certificates of deposit, commercial and industrial loans, commercial real estate loans, construction and development loans, residential mortgages, consumer loans, credit cards, online banking, telephone banking, and mobile banking.

Share on Social Networks: